Matches in Wikidata for { <http://www.wikidata.org/entity/Q80279663> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- Q80279663 description "artículu científicu espublizáu n'abril de 2007" @default.
- Q80279663 description "im April 2007 veröffentlichter wissenschaftlicher Artikel" @default.
- Q80279663 description "scientific article published on 27 April 2007" @default.
- Q80279663 description "wetenschappelijk artikel" @default.
- Q80279663 description "наукова стаття, опублікована у квітні 2007" @default.
- Q80279663 name "A multicentre, randomised prospective trial comparing three intravesical adjuvant therapies for intermediate-risk superficial bladder cancer: low-dose bacillus Calmette-Guerin (27 mg) versus very low-dose bacillus Calmette-Guerin (13.5 mg) versus mi" @default.
- Q80279663 name "A multicentre, randomised prospective trial comparing three intravesical adjuvant therapies for intermediate-risk superficial bladder cancer: low-dose bacillus Calmette-Guerin (27 mg) versus very low-dose bacillus Calmette-Guerin (13.5 mg) versus mi" @default.
- Q80279663 type Item @default.
- Q80279663 label "A multicentre, randomised prospective trial comparing three intravesical adjuvant therapies for intermediate-risk superficial bladder cancer: low-dose bacillus Calmette-Guerin (27 mg) versus very low-dose bacillus Calmette-Guerin (13.5 mg) versus mi" @default.
- Q80279663 label "A multicentre, randomised prospective trial comparing three intravesical adjuvant therapies for intermediate-risk superficial bladder cancer: low-dose bacillus Calmette-Guerin (27 mg) versus very low-dose bacillus Calmette-Guerin (13.5 mg) versus mi" @default.
- Q80279663 prefLabel "A multicentre, randomised prospective trial comparing three intravesical adjuvant therapies for intermediate-risk superficial bladder cancer: low-dose bacillus Calmette-Guerin (27 mg) versus very low-dose bacillus Calmette-Guerin (13.5 mg) versus mi" @default.
- Q80279663 prefLabel "A multicentre, randomised prospective trial comparing three intravesical adjuvant therapies for intermediate-risk superficial bladder cancer: low-dose bacillus Calmette-Guerin (27 mg) versus very low-dose bacillus Calmette-Guerin (13.5 mg) versus mi" @default.
- Q80279663 P1433 Q80279663-74806CFA-7AD5-4D6D-ACB8-AFD523C51F45 @default.
- Q80279663 P1476 Q80279663-8A174E58-F0D4-4746-A659-F18611A1F605 @default.
- Q80279663 P2093 Q80279663-0D945775-8F74-48CB-8659-506B9ACF4D37 @default.
- Q80279663 P2093 Q80279663-23C02B14-CDDB-4D45-AAE3-0C844A73C2DB @default.
- Q80279663 P2093 Q80279663-2C199646-8C10-4D08-996F-258CBD533EB6 @default.
- Q80279663 P2093 Q80279663-31AC83C2-96B8-4D2F-B745-DA453CC0C63F @default.
- Q80279663 P2093 Q80279663-4550688C-DB66-4B45-95C0-DD3C43F39D1C @default.
- Q80279663 P2093 Q80279663-4E6A4AEC-5568-485A-BCBA-2F614B9867DC @default.
- Q80279663 P2093 Q80279663-5516A2C4-E7AF-4807-A13F-2D3A1D887E97 @default.
- Q80279663 P2093 Q80279663-8BC04B61-5BE8-4D3F-80C2-ABB2E2955BEF @default.
- Q80279663 P2093 Q80279663-94CD0F6E-D528-454B-BD04-A537B8A51144 @default.
- Q80279663 P2093 Q80279663-ACE3BF9C-AEA6-4476-97B5-B6A45194E322 @default.
- Q80279663 P2093 Q80279663-C0C573D9-0441-4300-83B5-5B5D0FE61788 @default.
- Q80279663 P2093 Q80279663-CA8AE610-4D09-4CAD-8735-043FA936DB57 @default.
- Q80279663 P2093 Q80279663-D4CA0B07-D218-44C8-99FD-EFCDA05613DE @default.
- Q80279663 P2093 Q80279663-DDCF2D4A-DFE9-4736-920A-853354E68D0F @default.
- Q80279663 P2093 Q80279663-ED5A158E-5D7E-4925-8E18-7E2C109831DB @default.
- Q80279663 P304 Q80279663-D96A1329-A7B5-40A8-881E-89757FED5247 @default.
- Q80279663 P31 Q80279663-2C80E40C-5039-45AF-96D3-0A036DA863BC @default.
- Q80279663 P356 Q80279663-743BF7BA-E636-4142-9FA5-DE599BC36471 @default.
- Q80279663 P433 Q80279663-0165A5C9-79F7-40E2-A78E-4F72FAD7E58C @default.
- Q80279663 P478 Q80279663-C431FD0F-5916-4BDD-8F11-D131B6ED608B @default.
- Q80279663 P577 Q80279663-C23DB1B7-173E-46C8-B7C2-4DB3C4CB1B09 @default.
- Q80279663 P698 Q80279663-2E91E6D7-68EA-4137-BE7D-764F72A0DC7B @default.
- Q80279663 P921 Q80279663-6D12B1D9-5F80-42CF-8314-28607503CC31 @default.
- Q80279663 P921 Q80279663-9B37142F-62DA-40DD-9C4D-E51EBC617BC0 @default.
- Q80279663 P356 J.EURURO.2007.04.062 @default.
- Q80279663 P698 17485161 @default.
- Q80279663 P1433 Q15763991 @default.
- Q80279663 P1476 "A multicentre, randomised prospective trial comparing three intravesical adjuvant therapies for intermediate-risk superficial bladder cancer: low-dose bacillus Calmette-Guerin (27 mg) versus very low-dose bacillus Calmette-Guerin (13.5 mg) versus mitomycin C" @default.
- Q80279663 P2093 "Antonio Ojea" @default.
- Q80279663 P2093 "CUETO Group (Club Urológico Español De Tratamiento Oncológico)" @default.
- Q80279663 P2093 "Eduardo Solsona" @default.
- Q80279663 P2093 "Jesús María Fernández Gómez" @default.
- Q80279663 P2093 "Jesús Rodríguez Molina" @default.
- Q80279663 P2093 "José A Martínez-Piñeiro" @default.
- Q80279663 P2093 "José Emilio Camacho" @default.
- Q80279663 P2093 "José Luís Nogueira" @default.
- Q80279663 P2093 "Luís Martínez Piñeiro" @default.
- Q80279663 P2093 "Miguel Blas" @default.
- Q80279663 P2093 "Nicolás Flores" @default.
- Q80279663 P2093 "Rafael Hernandez Rodríguez" @default.
- Q80279663 P2093 "Rosario Madero" @default.
- Q80279663 P2093 "Santiago Isorna" @default.
- Q80279663 P2093 "Venancio Chantada" @default.
- Q80279663 P304 "1398-1406" @default.
- Q80279663 P31 Q13442814 @default.
- Q80279663 P356 "10.1016/J.EURURO.2007.04.062" @default.
- Q80279663 P433 "5" @default.
- Q80279663 P478 "52" @default.
- Q80279663 P577 "2007-04-27T00:00:00Z" @default.
- Q80279663 P698 "17485161" @default.
- Q80279663 P921 Q504775 @default.
- Q80279663 P921 Q6934595 @default.